The effect of P2X7 antagonism on subcortical spread of optogenetically-triggered cortical spreading depression and neuroinflammation

J Headache Pain. 2024 Jul 24;25(1):120. doi: 10.1186/s10194-024-01807-1.

Abstract

Migraine is a neurological disorder characterized by episodes of severe headache. Cortical spreading depression (CSD), the electrophysiological equivalent of migraine aura, results in opening of pannexin 1 megachannels that release ATP and triggers parenchymal neuroinflammatory signaling cascade in the cortex. Migraine symptoms suggesting subcortical dysfunction bring subcortical spread of CSD under the light. Here, we investigated the role of purinergic P2X7 receptors on the subcortical spread of CSD and its consequent neuroinflammation using a potent and selective P2X7R antagonist, JNJ-47965567. P2X7R antagonism had no effect on the CSD threshold and characteristics but increased the latency to hypothalamic voltage deflection following CSD suggesting that ATP acts as a mediator in the subcortical spread. P2X7R antagonism also prevented cortical and subcortical neuronal activation following CSD, revealed by bilateral decrease in c-fos positive neuron count, and halted CSD-induced neuroinflammation revealed by decreased neuronal HMGB1 release and decreased nuclear translocation of NF-kappa B-p65 in astrocytes. In conclusion, our data suggest that P2X7R plays a role in CSD-induced neuroinflammation, subcortical spread of CSD and CSD-induced neuronal activation hence can be a potential target.

Keywords: CSD; Migraine; Neuroinflammation; P2X7R; Subcortical spread.

MeSH terms

  • Animals
  • Cortical Spreading Depression* / drug effects
  • Cortical Spreading Depression* / physiology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Migraine Disorders / drug therapy
  • Migraine Disorders / metabolism
  • Migraine Disorders / physiopathology
  • Neuroinflammatory Diseases*
  • Neurons / drug effects
  • Niacinamide / analogs & derivatives
  • Optogenetics
  • Piperazines
  • Purinergic P2X Receptor Antagonists* / pharmacology
  • Receptors, Purinergic P2X7* / drug effects
  • Receptors, Purinergic P2X7* / metabolism

Substances

  • Purinergic P2X Receptor Antagonists
  • Receptors, Purinergic P2X7
  • JNJ-47965567
  • Niacinamide
  • Piperazines